ArticleThe Journal of antimicrobial chemotherapy2025

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

Inés Suárez-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.